Covid-19 may raise risk of developing multiple sclerosis

Covid-19 may be a risk factor for multiple sclerosis (MS). This has been shown by new research at örebro University and örebro University Hospital, Sweden.

Astellas agrees to take over Propella Therapeutics for $175m

Share this article Astellas plans to fund the acquisition of Propella using cash on hand. Credit: JHVEPhoto / Shutterstock.com. Astellas Pharma has signed an agreement for

November 16, 2023

Study reveals altered neural signature in patients with depression

As parents, teachers and pet owners can attest, rewards play a huge role in shaping behaviors in humans and animals.

July 15, 2024

Addressing barriers to healthcare delivery for people with Alzheimer’s disease and related dementias

Kosali Simon, PhD, M.A., a professor with the Paul H. O’Neill School of Public and Environmental Affairs and a Regenstrief Institute research scientist; and Katherine

January 3, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.